Remove 2016 Remove Networking Remove Pharma Remove Side effects
article thumbnail

Biogen: This train wreck was due

World of DTC Marketing

When George Scangos resigned in 2016, he must have known that the future was bleak. Biogen went from being agile biotech to big pharma. The MS community, which is very active on social media, complained about the side effects of Biogen’s drug while praising new competitors’ drugs.

Training 231
article thumbnail

Novel oral chemotherapeutic holds potential for stomach cancer patients

European Pharmaceutical Review

There is an urgent need for more effective chemotherapy treatments with less severe toxicity and side effects. Irinotecan – also known by the brand name Campto/Camptosar ® (Pfizer Ltd.) – has proven to be an effective chemotherapy agent against several types of gastrointestinal cancer. About the author.

article thumbnail

The case for AI and machine learning in life sciences

Pharmaceutical Technology

Healthcare and pharma are often at the forefront of new innovations, but it is a highly regulated industry, and change can sometimes be slow. Neural networks learn to “translate” from language A to language B.